Neuren Pharmaceuticals Limited (NURPF) Financials

NURPF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 235.1 million 5.0 million
Dec. 31, 2025 228.9 million 2.9 million
June 30, 2025 217.8 million 5.2 million
Dec. 31, 2024 254.6 million 28.5 million

NURPF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 5.5 million ?
Dec. 31, 2025 -1.9 million ?
June 30, 2025 84.4 million 336698
Dec. 31, 2024 5.8 million 289560

NURPF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 3.3 million
Dec. 31, 2025 10.3 million
June 30, 2025 9.9 million
Dec. 31, 2024 83.3 million

NURPF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 197.8 million - -
Dec. 31, 2025 197.7 million - -
June 30, 2025 197.0 million - -
Dec. 31, 2024 138.1 million - -

NURPF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 87.9 million
Dec. 31, 2025 88.5 million
June 30, 2025 84.8 million
Dec. 31, 2024 81.2 million

NURPF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 5521 18.9 million - -
Dec. 31, 2025 21365 14.4 million - -
June 30, 2025 3288 9.8 million 1.6 million -
Dec. 31, 2024 4349 9.4 million 1.4 million -

NURPF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 22.9 million 9662
Dec. 31, 2025 24.3 million 8011
June 30, 2025 18.6 million 9.8 million
Dec. 31, 2024 119.6 million 9.4 million

NURPF

Price: $14.28

52 week price:
7.70
17.25

Dividend Yield: 0.73%

Earnings Per Share: 0.11 USD

P/E Ratio: 146.36

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.8 billion

Links: